Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

236
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
236
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

15.8K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
15.8K
Inflammation01:38

Inflammation

61.4K
Overview
61.4K
Inflammatory Response II: Inflammatory Exudate and Tissue Repair01:24

Inflammatory Response II: Inflammatory Exudate and Tissue Repair

7.2K
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
7.2K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

256
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
256
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

171
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
171

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consecutive PRES and diffuse alveolar hemorrhage in a patient with active lupus nephritis and antiphospholipid antibodies: a case report and systematic literature review.

BMC nephrology·2026
Same author

Socioeconomic status in Behçet's syndrome.

Clinical and experimental rheumatology·2026
Same author

Reply to the comment on: Carotid artery ultrasonography and shear wave elastography in Takayasu's arteritis: a comparative analysis with diabetes mellitus.

Clinical and experimental rheumatology·2026
Same author

Comment on: Prevalence, incidence and geographical distribution of familial Mediterranean fever in Turkey.

Clinical and experimental rheumatology·2026
Same author

Internal carotid artery involvement and stroke risk in Takayasu arteritis: a case-control study.

Rheumatology international·2026
Same author

Efficacy and tolerability of switching from coated to compressed colchicine preparations in patients with Behçet's syndrome.

Rheumatology (Oxford, England)·2026

Related Experiment Video

Updated: Jan 6, 2026

Intravital Microscopy of Leukocyte-endothelial and Platelet-leukocyte Interactions in Mesenterial Veins in Mice
05:12

Intravital Microscopy of Leukocyte-endothelial and Platelet-leukocyte Interactions in Mesenterial Veins in Mice

Published on: August 13, 2015

12.9K

Venous involvement in inflammatory disorders.

Emire Seyahi1

  • 1Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul-Cerrahpasa, Istanbul, Turkey.

Current Opinion in Rheumatology
|October 11, 2019
PubMed
Summary

Inflammatory disorders like Behçet's syndrome and inflammatory bowel disease (IBD) increase venous thrombosis risk. Understanding inflammation-induced thrombosis mechanisms is crucial for effective prevention and treatment strategies.

Area of Science:

  • Rheumatology
  • Hematology
  • Gastroenterology

Background:

  • Systemic inflammatory diseases are linked to a higher risk of venous thrombosis.
  • Behçet's syndrome serves as a model for inflammation-induced thrombosis, with increased venous wall thickness observed even without prior thrombosis.
  • Inflammatory bowel disease (IBD) patients face a 2-3 fold increased risk of thromboembolic complications, particularly ulcerative colitis post-surgery.

Purpose of the Study:

  • To review the association between venous thrombosis and various inflammatory disorders.
  • To highlight the unique aspects of thrombosis in Behçet's syndrome and IBD.
  • To identify gaps in understanding and treatment of inflammation-associated thrombosis.

Main Methods:

  • Literature review of studies on venous thrombosis in systemic inflammatory diseases.

More Related Videos

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

6.9K
Analyzing the Effects of Stromal Cells on the Recruitment of Leukocytes from Flow
11:30

Analyzing the Effects of Stromal Cells on the Recruitment of Leukocytes from Flow

Published on: January 7, 2015

10.6K

Related Experiment Videos

Last Updated: Jan 6, 2026

Intravital Microscopy of Leukocyte-endothelial and Platelet-leukocyte Interactions in Mesenterial Veins in Mice
05:12

Intravital Microscopy of Leukocyte-endothelial and Platelet-leukocyte Interactions in Mesenterial Veins in Mice

Published on: August 13, 2015

12.9K
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

6.9K
Analyzing the Effects of Stromal Cells on the Recruitment of Leukocytes from Flow
11:30

Analyzing the Effects of Stromal Cells on the Recruitment of Leukocytes from Flow

Published on: January 7, 2015

10.6K
  • Analysis of recent findings on venous wall thickness and thrombotic risk in specific conditions.
  • Synthesis of current treatment approaches and uncertainties.

    • Main Results:

    • Behçet's syndrome and IBD are significantly associated with increased venous thrombosis risk.
    • Thrombosis in Behçet's syndrome may represent a distinct inflammation-driven process.
    • Antineutrophil cytoplasmic antibody-associated vasculitides and ankylosing spondylitis also carry thrombotic risks.

    Conclusions:

    • The mechanisms underlying venous thrombosis in inflammatory disorders require further investigation.
    • Optimal strategies for prevention, screening, and treatment (immunosuppression vs. anticoagulation) remain unclear.
    • Intensified research into the inflammation-thrombosis link is essential.